Public Company News

Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress

CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- The 2025 European Society for Medical Oncology (ESMO) Congress will take place inBerlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) will present results from multiple clinical stud...

2025-09-23 17:03 1663

Kingsoft Cloud Announces Proposed Offering of New Shares

BEIJING, Sept. 23, 2025 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("Kingsoft Cloud" or the "Company") (NASDAQ: KC and HKEX: 3896), a leading cloud service provider inChina, today announced that it proposes to offer 282,000,000 ordinary shares of the Company (the "Placing Shares") in offshor...

2025-09-23 17:00 1204

LSEG and Databricks Partner to Bring AI-Ready Financial Data Natively to Databricks for Analytics, AI Apps and Agents

With Databricks Agent Bricks, financial teams can build governed AI agents on their enterprise data and LSEG's industry-leading data LONDON, Sept. 23, 2025 /PRNewswire/ -- LSEG  and D...

2025-09-23 17:00 2666

Hanon Systems Announces Rights Offering of Approximately 900 Billion KRW to Strengthen Financial Stability

* The capital increase is designed to enhance corporate value and secure operational funds for sustainable growth * A portion of the funds will be used for debt repayment to strengthen the company's financial stability * Rights offering to be conducted through shareholder allocation and publ...

2025-09-23 16:42 1628

KT&G announces additional shareholder returns, setting annual dividend per share at 6,000 KRW, signs MOU with Altria on nicotine pouch, etc.

* Additional share repurchase & cancelation of 260b KRW, targets double digit operating profit and revenue growth based on solid global business  * Signs comprehensive MOU with American tobacco manufacturer Altria, for collaboration in all areas including nicotine pouch and health functional f...

2025-09-23 16:31 2868

Appier Announces Full Product Line Infused with Agentic AI, Ushering in a New Era of ROI Driven Marketing Solutions

Reshaping the Marketing Ecosystem with Autonomous, Adaptive and Agentic AI TAIPEI, Sept. 23, 2025 /PRNewswire/ -- Appier (TSE: 4180), a leading AI native software company, today announced the infusion of Agentic AI across its entire product portfolio and the launch of eight purpose built AI Agent...

2025-09-23 14:45 3629

Desay SV Celebrates Key Milestone in European Development with Spanish Intelligent Factory Structural Completion

LINARES, Spain, Sept. 23, 2025 /PRNewswire/ -- On September 19, 2025, Desay SV celebrated the structural completion of its intelligent factory at Linares, a joint project with the local government. The milestone underscores a key step in the Desay SV European growth strategy. The ceremony brought...

2025-09-23 14:30 1346

Mindray Unveils Project 2030 and Re-writes the Future of Women's Health Ultrasound at ISUOG

CANCUN, Mexico, Sept. 23, 2025 /PRNewswire/ -- On September 15th, at ISUOG 2025 World Congress inCancun, Mexico, Mindray unveiled Project 2030, an initiative to improve global access to ultrasound technology. The project was launched to an international audience of leading specialists, capping a ...

2025-09-23 13:48 1182

WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year

SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been selected as a constituent company of the FTSE4Good Index Series, marking the fifth consecutive year the company h...

2025-09-23 12:00 3024

Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC

CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged during transfection (RET) kinase inhibitor A400 (also known as EP0031) was accepted for review ...

2025-09-23 10:22 1430

GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

YONGIN, South Korea, Sept. 22, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety (MFDS) inSouth Korea for a Phase 1 clinical tria...

2025-09-23 09:41 1453

Angel Yeast's Breakthrough in Yeast Protein Research: AngeoPro Shown to Promote Calcium Absorption, Aiding in Osteoporosis Prevention

YICHANG, China, Sept. 23, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a leading global food ingredients and biotechnology company, today announced a major advancement in research on its yeast protein product AngeoPro. New scientific studies confirm that yeast protein...

2025-09-23 09:00 800

Health In Tech's Upgraded eDIYBS Unlocks Large-Employer Underwriting with Speed and Scale

STUART, Fla., Sept. 22, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced a major expansion of its Enhanced Do-It-Yourself Benefit System (eDIYBS). Previously, a fast and simple underwriting solution focusing on s...

2025-09-23 05:00 2844

AT&T Receives Frost & Sullivan's 2025 Global Market Leadership Recognition for Passenger Vehicle Connectivity

Frost & Sullivan applauds AT&T's global market leadership in passenger vehicle connectivity, which is underpinned by unmatched network coverage, customer-centric innovation, and flexible business models. SAN ANTONIO, Sept. 22, 2025 /PRNewswire/ -- Frost & Sullivan

2025-09-22 22:00 1899

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeuti...

2025-09-22 21:00 1953

DXC Ranked a Leader in ISG Provider Lens™ ServiceNow Ecosystem Partners 2025 Study

* DXC is ranked a leader across all categories in the US, AP&J, and Europe. * ISG highlighted DXC's leadership through its joint Center of Excellence with ServiceNow, aimed at accelerating GenAI adoption and driving innovation ASHBURN, Va., Sept. 22, 2025 /PRNewswire/ -- DXC Technology (NYSE: ...

2025-09-22 21:00 1731

NYSE Content Advisory: Pre-Market update + Mike Waltz, U.S. Ambassador to UN, rings Opening Bell

NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market update + Mike Waltz, U.S. Amb...

2025-09-22 20:55 2796

Shanghai Electric Deepens Cooperation to Jointly Build the China-Pakistan Economic Corridor with Energy and Talent as Key Drivers

* Pakistani President Asif Ali Zardari Visits Shanghai Electric Headquarters * Thar Flagship Project and Talent Development Program Bring China-Pakistan Economic Corridor Cooperation to New Heights SHANGHAI, Sept. 22, 2025 /PRNewswire/ -- Pakistani President Asif Ali Zardari visited the headqu...

2025-09-22 20:51 2148

Locksley Continues to Strengthen its Position in Paving Pathway to 100% Made in America

Company Reports Exceptional Initial Metallurgical Results for Its US Mojave Project SAN BERNARDINO, Calif, Sept. 22, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has achieved significant results from initial metallurgical testwork completed by the company on...

2025-09-22 20:10 3060

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious ...

2025-09-22 20:00 2978
1 ... 83848586878889 ... 1666

Week's Top Stories